Keys to Prevention and Risk Reduction with Antiplatelet Therapy in Patients with Acute Ischemic Stroke and Transient Ischemic Attack
March 13, 2022
In this program, Chair Dr. S. Claiborne Johnston, Dr. Brett Cucchiara, Dr. Louise McCullough, and Dr. Carlos Molina will interpret the evidence for DAPT, provide insights into the choice of clopidogrel or ticagrelor to add to ASA, describe deficiencies in care preventing optimal use of DAPT, and explain remedies.
No Credit Available
Tailoring LDL-C-Lowering Therapy to Patient Cardiovascular Risk: Identifying Effective Strategies for Patients with Diabetes
November 30, 2019
In this program, a panel of experts will discuss the latest guidelines for managing LDL-C in patients with diabetes, interpret data with nonstatin, LDL-C-lowering therapies, describe improving access to PCSK9 inhibitors and tips for achieving earlier access,
No Credit Available
Stable Ischemic Heart Disease Management: Challenges and Controversies
November 17, 2014
Valentin Fuster, MD, PhD (Co-Chair), Peter Stone, MD (Co-Chair) lead discussion of best practices and controversies in SIHD
No Credit Available